Gennemsnitshalveringstiderne i eliminationsfasen for loratadin og dets metabolit var ikke signifikant forskellige fra dem der var observeret hos raske personer.
The mean elimination half-lives of loratadine and its metabolite were not significantly different from that observed in normal subjects.